Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

HEMA > HEMA > Flashcards

HEMA Flashcards

1
Q

normochromic ,normocytic ,or macrocytic and are characterized by a low reticulocytecount

A

Hypoproliferative anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pancytopenia with Hypocellular Bone Marrow

A

– Acquired aplastic anemia
– Constitutional aplastic anemia Some myelodysplasia
– Rare aleukemic leukemia
– Some lymphomas of bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pancytopenia with Cellular Bone Marrow

PRIMARY BONE DISEASE

A 
Myelodysplasia
PNH
Myelofibrosis
Myelophthisis
Bone Marrow Lymphoma
Hairy Cell Leukemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pancytopenia with Cellular Bone Marrow

SECONDARY CAUSES

A 
SLE
Alcohol intake
Cobalamin deficiency
Hypersplenism
Overwhelming Infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q 
Acquired
o Chemical Exposure, Radiation, Viral Infection, Immune Mediated Disorders, Paroxysmal Nocturnal hemoglobinuria, Pregnancy
– Idiopathic
– Hereditary
o Fanconi’s Anemia
o Dyskeratosis Congenita
o Shwachman-Diamond syndrome
A

APLASTIC ANEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

notorious cause of bone marrow failure

A

Chemicals- Benzene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

is the most common preceding infection, and posthepatitis marrow failure accounts for approximately 5% of etiologies in most series

A

Hepatitis infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A major consequence and the inevitable cause of death in transfusion-associated graft-versus-host disease (GVHD)

A

Immunologic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Symptomatic anemia and Hemorrhage.
– Presence of infection
– Discovered serendipitously at preoperative evaluation, blood donation, or from screening tests

A

APLASTIC ANEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Acquired Aplastic Anemia MECHANISMS

A
  1. Direct toxicity to hematopoietic multipotential cells (HSCs)
  2. A defect in the stromal microenvironment of the marrow required for hematopoietic cell development
  3. Impaired production or release of essential multilineage hematopoietic growth factors
  4. Cellular or humoral immune suppression of the marrow multipotential cells
  5. Progressive erosion of chromosome telomeres.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DIAGNOSTICS FOR APLASTIC ANEMIA

A 
– Findings of Pancytopenia
– An elevated mean corpuscular volume is frequent in aplastic anemia at presentation.
– Bone Marrow Biopsy
o The “empty” marrow on histology
o Erythroid islands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fever or documented infection occuring in the presence of severe neutropenia (<500/uL IS TREATED WITH

A

Broad spectrum parenteral antibiotic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

__________is preferred when feasible as it is curative.

_________ is most commonly used as first therapy in the United States and worldwide

A

Hematopoietic Stem Cell Transplantation (HSCT)

Immunosupressive Treatment (IST)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immunossuppressive therapy (IST) COMPONENTS

A

Standard initial IST is horse Anti Thymocyte Globulin (ATG) and Cycolsporine (CsA),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

APLASTIC ANEMIA DUE TO CONSTITUTIONAL DISORDERS

A
  1. FANCONIS ANEMIA
  2. DYSKERATOSIS CONGENITA
  3. SHWACHMAN-DIAMOND SYNDROME
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

an autosomal recessive disorder, progressive pancytopenia, and an increased risk of malignancy.
– Typically have short stature, cafe au lait spots, and anomalies involving the thumb, radius, and genitourinary tract.

A

FANCONIS ANEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q 
An aplastic anemia of childhood due to mutations in genes of the telomere repair complex due to mutations in the DKC1 (dyskerin) gene;
– Triad of :
o Mucous membrane leukoplasia
o Dystrophic nails
o Reticular hyperpigmentation
A

DYSKERATOSIS CONGENITA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Presents early in life with neutropenia, pancreatic insufficiency and malabsorption.
– Most patients have compound heterozygous mutations in SBDS that may affect both ribosomal biogenesis and marrow stroma function

A

SHWACHMAN-DIAMOND SYNDROME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

characterized by anemia, reticulocytopenia, and absent or rare erythroid precursor cells in the bone marrow, associated with immune system diseases.

A

PURE RED CELL APLASIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ETIOLOGY OF PURE RED CELL APLASIA

A

ETIOLOGY
– Thymoma.
– Large Granular Lymphocytosis (LGL) or complicate chronic lymphocytic leukemia (CLL).
– Strongly associated with the 5th disease caused by B19 Parvovirus Infection.
– Subcutaneous administration of erythropoietin (EPO) has provoked PRCA mediated by neutralizing antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

TX OF PRCA

A 
Intravenous Immunoglobulin (IVIg)
– Corticosteroids
– Cyclosporine with ATG
– Azathioprine
– Cyclophosphamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cytopenias due to bone marrow failure
o High risk of development of acute myeloid leukemia
o is a disease of the elderly; the mean age at onset is older than 70 years with a slight male preponderance

A

MYELODYSPLASIA (MDS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

A group of clonal bone marrow stem cell disorders, presenting with hypercellular marrow, peripheral cytopenias, and cell functional abnormalities due to Ineffective Hematopoiesis

A

MYELODYSPLASIA (MDS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Dysplasia in ≥10% of cells from a single myeloid lineage <5% marrow blasts, <1% blood blasts, and noAuer rods , <15% of erythroid precursors are ring sideroblasts.

A

Refractory cytopenia with unilineage dysplasia (RCUD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

o Isolated erythroid dysplasia <5% marrow blasts, <1% blood blasts, and no Auer rods, ≥15% of erythroid precursors are ring sideroblasts

A

Refractory anemia with ring sideroblasts (RARS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

5Q31 deletion as the sole chromosomal abnormality and is associated with increased megakaryocytes

A

Myelodysplastic syndromes (MDS) associated with isolated del (5Q)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Dysplasia in ≥10% of cells from two or more myeloid lineages <5% marrow blasts, <1% blood blasts, and no Auer rods, Blood monocyte count <1 × 109/L

A

Refractory cytopenia with multilineage dysplasia (RCMD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Type 1: 5–9% marrow blasts, <5% blood blasts, and no Auer rods
o Type 2: 10–19% marrow blasts, 5–19% blood blasts, or Auer rods Blood monocyte count <1 × 109/L

A

Refractory anemia with excess blasts (RAEB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Minimal dysplasia the presence of a clonal cytogenetic lesion considered presumptive evidence of MDS

A

Unclassifiable MDS (MDS-U)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

ETIOLOGY OF MDS

A 
Acquired:
o Senescence
o Mutagen/Genotoxic Stress
 Therapeutic
 alkylators, Topo-II agents,
 B-emitters (32P), autoSCT
 Environmental/occupational (benzene)
 Tobacco
o Aplastic anemia
o PNH
– Heritable:
o Constitutional genetic disorders
 Trisomy 8 mosaicism
 Familial monosomy 7
o Neurofibromatosis 1
o Embryonal dysgenesis (dEL12p)
o Congenital Neutropenia
 Kostmann, Schwachman-Diamond DNA repair deficiencies
 Fanconi anemia, AT, Bloom syndrome
o Pharmacogenomic polymorphisms (GSTq1-null)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

DIAGNOSTIC CRITERIA OF MDS

A

Presence of one or more otherwise unexplained cytopenias
o Hemoglobin <11 g/dL
o Absolute neutrophil count <1500/μL
o Platelet count <100,000/μL
– >10% dysplastic cells in erythroid, myeloid, and/or megakaryocyte lineages
– 5 to 19% marrow blasts
– Evidence of a cytogenetic abnormality typical for MDS
– Presence of one or more myelodysplastic syndrome (MDS) decisive criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

TX OF MDS

A 
CHEMOTHERAPEUTIC AGENTS
– Azacitadine
– Decitabine
– Lenalidomide (del 5Q)
– Cytarabine
– Immunosuppressive Agents
– EPO
– Supportive transfusion with iron Chelation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Fibrosis of the bone marrow usually accompanied by a characteristic blood smear picture called ____________, can occur as a primary hematologic disease, called ____________

A

MYELOPHTHISIC MARROW

leukoerythroblastosis

myelofibrosis or myeloid metaplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

ETIOLOGY OF..
Fibrosis can be a response to invading tumor cells, usually an epithelial cancer of breast, lung, or prostate origin or neuroblastoma.
– Infection of mycobacteria, fungi, or HIV and in sarcoidosis.

A

MYELOPHTHISIC MARROW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

The pathophysiology has three distinct features
– Proliferation of fibroblasts in the marrow space (myelofibrosis)
– Extension of hematopoiesis into the long bones and into extramedullary sites, usually the spleen, liver, and lymph nodes (myeloid metaplasia)
– Ineffective erythropoiesis.

A

MYELOPHTHISIC MARROW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

CHRONIC INFLAMMATION
– Inflammatory cytokine
release (IL-6) triggers
release of _____

A

Hepcidin regulates iron
absorption and release
depriving effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Progressive CKD is usually associated with a moderate to severe hypoproliferative anemia
– The level of the anemia correlates with the stage of CKD.
– The anemia is primarily due to a failure of EPO production by the diseased kidney and a reduction in red cell survival
– Patients with the anemia of CKD usually present with normal serum iron, TIBC, and ferritin levels.
– However, those maintained on chronic hemodialysis may develop iron deficiency from blood loss through the dialysis procedure.

A

ANEMIA OF RENAL DISEASE

38
Q

The heme moiety binds O2, providing the means to circulate O2 from the lungs to tissues.
– The active site of electron transport in cytochromes and cytochrome oxygenase, essential coenzymes in the Krebs cycle.

A

HYPOCHROMIC, MICROCYTIC ANEMIA

39
Q

It is the most prevalent form of malnutrition globally

A

IRON DEFICIENCY ANEMIA (IDA)

40
Q

SX OF IDA

A

Cheilosis

– Koilonychia

41
Q

LAB FREATURE OF IDA

A 
Red cell indices:
o Low Hb conc.
o MCV, MCH, MCHC ↓
– Blood film:
Hypochromic microcytic
o Pencil shaped poikilocytes
o Occasional Target cells.
o Reactive Thromocytosis
42
Q

most convenient test to estimate Iron Stores

A

Serum Ferritin:

43
Q

indirect measurement of

bound/unbound transferrin

A

– Total iron binding capacity:

44
Q

STAGES OF IDA

Demands for( or losses of) Iron exceed the body’s ability to
absorb Iron from the diet
– Blood loss in excess of 10-20mL exceeds the absorbed from diet

A

Negative Iron Balance

45
Q

Hemoglobin synthesis becomes decreased once the transferrin
saturations falls to 15 to 20%
– Microcytes

A

Iron Deficient Erythropoiesis

46
Q

Hemoglobin and Hematocrit begin to fall
– The transferrin saturation at his point is 10-15%
o Hypoproliferation

A

Iron Deficiency Anemia

47
Q

DIFFERENTIALS

OF IDA

A

INFLAMMATION
THALASSEMIA
SIDEROBLASTIC ANEMIA

48
Q

TX OF IDA

A 
Oral Iron preparations
– Parenteral Iron preparation
– Transfusion
Diet
– 3 ounce of serving of steak provides only about 3 mg of iron.
– 10 pounds of steak
Correct the Anemia
o Replenish Stores (0.5g to 1g)
o 6 to 12 months

Reticulocyte count increases by 4th to 7th day
– Hgb should increase halfway to a point between starting and
normal levels in an average of 18 days
– At 3 weeks, Hgb should have risen 5.9 +/- 17% toward Normal
– Iron tolerance test: Serum Iron determination done after 2
hours from intake of two Iron Tablets

49
Q

Absence of Response TO IDA

A 
Incorrect diagnosis of iron deficiency
– Blood loss greater than Hgb regeneration (in which case retics
should rise even if hgb does not)
– Inadequate prescription
– Noncompliance with therapy
– Iron malabsorption
– Superimposed infection, inflammation, malignancy or uremia
(Epo deficiency)
– Lead poisoning
– Concomitant folate or B12 deficiency
50
Q

Indications for Parenteral TherapY OF IDA

A

Unable to tolerate iron compounds orally
– Poor compliance
– Persistent loss of blood or iron at a rate too rapid for oral
intake to compensate for the loss
– Disorder of GI tract e.g. ulcerative colitis
– Malabsorption of iron
– Inability of maintain iron balance during treatment with
hemodialysis
– Donating large amounts of blood for auto transfusion

51
Q

Amount of Iron needed formula

A

– Body weight x 2.3 x (1.5 – Patients Hgb g/dL)

– + (500 or 1000mg)

52
Q

is reserved for individuals who have
symptoms of anemia, cardiovascular instability, continued and
excessive blood loss from whatever source, and require
immediate intervention

A

transfusion

53
Q

Inherited disorders of global biosynthesis causing ABNORMAL
supply of global
– Diminishes production of hemoglobin tetramers, causing
hypochromia and microcytosis

A

THALASSEMIA

54
Q

pathogenesis of thalassemia

A

Thalassemia most common genetic disorder in the world
– Inherited Autosomal Codominant Trait
– Deranged splicing of the mRNA precursor
– Premature termination of mRNA translation

55
Q 
sx of what disease
Jaundice
– Skull and other bones may be deformed
– Cortical bone thinning
– Hepatomegaly
– Bilirubin stones
– Splenomegaly
– Endocrine dysfunction
A

thalassemia

56
Q

Laboratory Features of thalassemia

–

A

CBC
– Peripheral blood smear
– Hgb Electrophoresis and column chromatography

57
Q

Peripheral Blood Smear of Thalassemia

A

Marked anisopoikilocytosis
– Hypochroomia
– Target cell formation (codocytes)
– Basophilic Stippling

58
Q

– A test to evaluate for and identify variant and abnormal
hemoglobins.
– Alkaline and/or citrate agar electrophoresis is the commonly
used method.
– Separation of hemoglobins is based on variable rates of
migration of charged hemoglobin molecules in an electrical
field

A

Hgb Electrophoresis

59
Q

Abnormal accumulation alpha chains causing formation of toxic
inclusions (Hemolytic Anemia).
o Erythroid Hyperplasia
o Extramedullary Hematopoietic Tissues

A

B THALASSEMIA

60
Q 
– Severe Homozygous
– Childhood, growth delay
– Severe anemia,Hepatosplenomegaly
– Requires transfusion
– Iron Overload
Hgb Electrophoresis
o Absent Hb A
o Increased Hb F
o Increased Hb A
A

Beta thalassemia major

61
Q 
Similar stigmata like major
– Survive without transfusion
– Moderate anemia, microcytosis, hypochromia
– Hb Electrophoresis
o HbF- 20-100%
o HbA2- 3.5%-5.5%
o HbA- 0.30%
A

Beta thalassemia intermedia

62
Q 
Profound microcytosis, target cells
– Minimal anemia
– Similar bld picture of iron def anemia
– Lab inv:
o MCV<75,Hct <30-33%
o Hb electr: HbA2-3.5-7.5%, HbA-80-95%, HbF-1-5%
A

Beta thalassemia minor

63
Q

Thalassemia Syndromes
o Deletion of one a globin loci
o Asymptomatic Carrier

A

a thal 2 trait (- a / a a)

64
Q 
Thalassemia Syndromes
o Cis (-a/-a)
o Trans (--/aa)
A

a thal 1 trait

65
Q 
Thalassemia Syndromes
o Offspring of a thal 1 and 2 trait
o Decrease of Hgb A 25-30%
o Increase in Hgb B chain
o Mod to severe hemolytic anemia
A

HbH (–/-a)

66
Q 
Thalassemia Syndromes
o Hgb Bart’s
o Accumulation of Gamma Globin
o High O2 Affinity deprives the fetus with Oxygen
o Hydrops Fetalis
A

Homozygous State a thal cis deletion (–/–)

67
Q

The primary goal of _____ is to
prevent the accumulation of iron reaching harmful
levels
o Commences by the time the serum ferritin level
reaches approximately 1000 mcg/dL.
o Careful monitoring of the degree of iron
accumulation during chelation therapy is absolutely
vital.
o a regular estimation of the serum ferritin level, which
should be maintained at less than 1500 mcg/L

A

Iron Chelation

68
Q

SC administration: 1-2g (20-40mg/kg/day) SC over 8-24 hours
– IV administration in patients with IV access: 40-50mg/kg/day
over 8-12 hours for 5-7 days/ week (maximum of <
60mg/kg/day and an IV infusion rate of <15mg/kg/hr)
– IM administration: 0.5-1g QD (Maximum of 1g QD)

A

Deferoxamine

69
Q

25-33 mg/kg PO TID (ie, total daily dosage range 75-99
mg/kg/day)
– Monitor serum ferritin concentration every 2-3 months to
assess the effects on body iron stores
– If the serum ferritin falls consistently <500 mcg/L, consider
temporarily interrupting therapy

A

Deferipone

70
Q

20-30 mg/kg taken orally by dissolving in water
– Metabolized in the liver
– Iron is excreted via the gut

A

Deferasirox

71
Q

Point mutation of 17th nucleotide in on chromosome 11 (β-globin gene) thymine to adenine
– 6th amino acid on the B-chains to glutamic acid → Valine
– Point mutation responsible for the distortion of normal RBCs
into sickle-shaped RBCs.

A

SICKLE CELL ANEMIA (SCA)

72
Q

Most Common Presentation SCA

A

Acute Painful Crisis

73
Q

The onset of chest pain, a temperature higher than 38.5°C,
tachypnea, wheezing, or cough.
– New or progressive pulmonary infiltrate in a patient with sickle
cell disease.
o Admit and treat

A

Acute Chest Syndrome

74
Q

Clinical Consequences of Sickle Disease

A 
Vaso-occlusion (pain)
– Stroke
– Proliferative retinopathy
– Acute Chest Syndrome/Pulmonary Hypertension
– Gallstones
– Splenic sequestration/infarcts/hyposplenism
– Renal insufficiency
– Avascularnecrosis
– Spontaneous pregnancy loss
– Priapism
– Osteonecrosis
– Non-healing skin ulcer
75
Q

dx of sca

A 
Clinical Presentation
– Hemoglobin electrophoresis
o HbS >80%
o HbF -1-20%
o HbA2 -2- 4.5%
– Hemolysis
– Sickle Cells (Drepanocytes)
76
Q

tx of sca

A 
Supportive care
o Hydration
o O2 supplementation
o Transfusion (especially for Acute Chest Syndrome)
o Pain Control (Aggressive Analgesia)
o Treat the underlying cause
– HYDROXYUREA
o 10-30 mg/kg
o Increases HbF
o Decrease Reticulocyte Count and Granulocytes.
– Azacytidine
– Bone Marrow Transplant
77
Q

Transfusion in Sickle Cell

A

– Simple transfusion – give blood
– Partial exchange transfusion - remove blood and give blood
– Erythrocytapheresis – use apheresis to maximize blood exchange

78
Q 
Symptoms associated with anemia
– Jaundice
– Hemoglobinuria (Tea Colored Urine)
– Organomegaly
o Splenomegaly
o Hepatomegaly
A

HEMOLYTIC ANEMIA

79
Q 
LABORATORY FEATURES
– CBC
o Hgb → Normal to Reduced
o MCV and MCH → Increased
– Reticulocyte Count → Increased
– Bilirubin levels → Increased
– LDH level → Increased
– Haptoglobulin level → decreased
A

hemolytic anemia

80
Q

– Predominantly warm type IgG
– May be part of an underlying condition
– Direct Antiblobulin Test (DAT)→ Coombs test
– May also present with thrombocytopenia (Evan’s) Syndrome
– Prednisone 1mg/kg
– Rituximab, Cyclosporine

A

AUTOIMMUNE HEMOLYTIC ANEMIA

81
Q

o Occurs after a viral infection

o Donath Landsteiner Anitbody

A

Paroxysmal Cold Hemoglobinuria

82
Q

o Antibodies that are active in Temp less than 370C
o Mostly IgM antibodies
o Associated with lymphoproliferative disorders or monoclonal B cell expansion
o Immunosuppresives not very effective as in AIHA

A

Cold Agglutinin Disease

83
Q

is a rare, clonal hematopoietic stem cell disorder that manifests with a hemolytic anemia from uncontrolled complement activation, propensity for thrombosis formation and the is associated syndrome of bone marrow failure.

A

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

84
Q

TREATMENT OF PNH

A

– Bone Marrow Transplant
o the only curative therapy
o associated with significant morbidity and mortality

85
Q 
Hypercellular Marrow
– Ineffective Erythropoiesis
– Macrocytosis (Increase in MCV)
– Cobalamin and Folate Deficencies
– DNA synthesis abnormalities
A

MEGALOBLASTIC ANEMIA

86
Q

Parent compound of a large family of natural folate compounds that are water soluble.
o They are partly or completely reduced to di- or tetrahydrofolate (THF) derivatives.
o They usually contain a single carbon unit.
o 70–90% of natural folates are folatepolyglutamates.

A

folates

87
Q 
CLINICAL FEATURES
– Symptoms related to anemia.
– Anorexia and Weight Loss.
– Diarrhea or Constipation.
– Glossitis or Angular Cheilosis.
– Mild fever in more severely anemic patients.
– Jaundice (unconjugated).
– Reversible Melanin skin hyperpigmentation.
– Increase susceptibility to infection
A

megaloblastic anemia

88
Q

OTHER TISSUES AFFECTED
– Epithelial Surface
o the next most frequently affected tissues
o Mouth, Stomach, Small Intestine
o Respiratory, Urinary, and Female Genital Tracts
o Macrocytosis and Multinucleated dying cells
– Pregnancy
o Prematurity
o Neural Tube Defects
– Cardiovascular
o Increase Homocysteine level
o Cerebrovascular, Peripheral vascular, Coronary Heart Disease and Deep Vein Thrombosis.
– Malignancy
o Increases Risk for malignancy in newborn
– Neurologic Manifestations
o Peripheral neuropathy and Cerebral symptoms.
o Optic Atrophy or Visual Impairment.
o Paresthesias, muscle weakness, or difficulty in walking
o Psychotic Disturbances, sometimes dementia

A

megaloblastic anemia

89
Q

CAUSES OF COBALAMIN DEFICIENCY

A 
– Diet → Vegan
– Pernicious Anemia
o Decrease in Intrinsfic Factor
– Gastrectomy
– Ileal Resection
– Tropical Spure
– Fish Tapeworm Manifestation
– Zollinger Ellison Syndrome
90
Q

CAUSES OF FOLATE DEFICIENCY

A 
– Nutritional
– Malabsoprtion
– Excess utilization
o Pregnancy
o Prematurity
o Hematologic Disorders
o Inflammation
– Antifolate Drugs
o Methotrexate
91
Q

LABORATORY FINDINGS of MA

A 
– Blood cell count
o macrocytic anemia ( MCV>100fl )
o thrombocytopenia (<40x109/L)
o Leucopenia (>1.5 × 109/L)
o low reticulocyte count
– Blood smear
o Macroovalocytosis
o Hypersegmentation

HEMA (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions